SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
- Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Matthew Dolan, Vice President Corporate Development will present an update on the company at the Raymond James & Associates’ 39th Annual Institutional Investors Conference in Orlando, Florida on Monday, March 5, 2018 at 8:40am (ET). The presentation, which will occur live at the JW Marriott Grande Lakes Hotel, will be concurrently webcast.
- Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Barclays Global Healthcare Conference in Miami Beach, Florida on Tuesday, March 13, 2018 at 2:35pm (ET). The presentation, which will occur live at the Loews Miami Beach Hotel, will be concurrently webcast.
The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.